Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is a common neurodegenerative disease, the pathological features of which include the presence of Lewy bodies and the neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta. However, until recently, research on the pathogenesis and treatment of PD have progressed slowly. Glutamate and dopamine are both important central neurotransmitters in mammals. A lack of enzymatic decomposition of extracellular glutamate results in glutamate accumulating at synapses, which is mainly absorbed by excitatory amino acid transporters (EAATs). Glutamate exerts its physiological effects by binding to and activating ligand-gated ion channels [ionotropic glutamate receptors (iGluRs)] and a class of G-protein-coupled receptors [metabotropic glutamate receptors (mGluRs)]. Timely clearance of glutamate from the synaptic cleft is necessary because high levels of extracellular glutamate overactivate glutamate receptors, resulting in excitotoxic effects in the central nervous system. Additionally, increased concentrations of extracellular glutamate inhibit cystine uptake, leading to glutathione depletion and oxidative glutamate toxicity. Studies have shown that oxidative glutamate toxicity in neurons lacking functional N-methyl-D-aspartate (NMDA) receptors may represent a component of the cellular death pathway induced by excitotoxicity. The association between inflammation and excitotoxicity (i.e., immunoexcitotoxicity) has received increased attention in recent years. Glial activation induces neuroinflammation and can stimulate excessive release of glutamate, which can induce excitotoxicity and, additionally, further exacerbate neuroinflammation. Glutamate, as an important central neurotransmitter, is closely related to the occurrence and development of PD. In this review, we discuss recent progress on elucidating glutamate as a relevant neurotransmitter in PD. Additionally, we summarize the relationship and commonality among glutamate excitotoxicity, oxidative toxicity, and immunoexcitotoxicity in order to posit a holistic view and molecular mechanism of glutamate toxicity in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, D., Wang, S., Wen, X., Han, X., Wang, Y., Shen, M., Fan, S., Zhuang, J., Zhang, Z.-F., Shan, Q., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27577 · Cited by 26 · cited 1×
“It has been reported that the increase of miR-543-3p and miR-342-3p in the PD model is associated with decreased expression and function of GLT-1 and increased accumulation of extracellular glutamate and that inhibition of either microRNAs can reverse the effect on the expression and function of GLT-1 and reduce dyski…”
BackgroundRetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972 · cited 3×
“The term “excitatory toxicity” was first proposed in 1986 to describe the ability of excessive extracellular glutamate to kill neurons by activating NMDARs (Choi, 1988; Meldrum and Garthwaite, 1990).”
BackgroundParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227 · cited 4×
“Release of presynaptic glutamate and activation of postsynaptic glutamate receptors on the postsynaptic neuron stimulate influx of Na and Ca2+ ions into the postsynaptic neuron, which contributes to depolarization and action potentials (Danbolt, 2001).”
BackgroundInfluentialFerroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727 · cited 1×
“In addition, the inhibition of the Xc system, the subsequent accumulation of ROS, and the decrease of GSH levels create a void in the antioxidant defenses of the cell, which may ultimately lead to ferroptosis (Dixon et al., 2012; Xie et al., 2016).”
BackgroundEpigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011 · cited 1×
“Epigenetics is currently defined as the study of stable and heritable patterns of gene expression that do not require any changes to the original DNA sequence (Egger et al., 2004; Bird, 2007).”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
The metabotropic glutamate receptors: Structure and functions
Pin, J.-P., & Duvoisin, R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00129-g · Cited by 2,266
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Niswender, C. M., & Conn, P. J. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,892 · cited 1×
“When the destructive elements are fully activated in microglia, they will show strong inflammatory and excitatory toxic reactions, exceeding the response level of physiological activation of microglia (Norden et al., 2015).”
BackgroundIonic dependence of glutamate neurotoxicity
Choi, D. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,802 · cited 1×
“Since overactivation of NMDARs is considered to be the main factor causing glutamate excitotoxicity (Choi, 1987), blocking these receptors is a potential strategy to prevent excitotoxicity.”
BackgroundExcitatory amino acid neurotoxicity and neurodegenerative disease
Meldrum, B., & Garthwaite, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90184-a · Cited by 1,771
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,752 · cited 1×
“…work has shown that EAATs contribute to the removal of synaptic glutamate, and the protein structures and functions of these transporters are closely related (Shaogang and Kanner, 2008; Crisman et al., 2009; Teichman et al., 2009; Zhang and Qu, 2012; Yunlong et al., 2014; Rong et al., 2015).”
BackgroundLocalization of neuronal and glial glutamate transporters
Rothstein, J. D., Martin, L., Levey, A. I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,702
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
Bergman, H., Wichmann, T., Karmon, B., & DeLong, M. R. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.2.507 · Cited by 1,365 · cited 1×
“proposed that excessive activation of glutamate receptors in nigrostriatal neurons might lead to cellular death via glutamate excitotoxicity (Bergman et al., 1994; Hassani et al., 1996; Benazzouz et al., 2002; Hutchison et al., 2010).”
BackgroundPathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283 · cited 1×
“The increase of free radicals is particularly important for the pathogenesis of PD, because dopaminergic neurons in the SNpc are particularly susceptible to oxidative stress (Julie and Patrik, 2002; Yuan et al., 2008; Mosharov et al., 2009; Benjamin et al., 2010).”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Cloning and expression of a rat brain L-glutamate transporter
Pines, G., Danbolt, N. C., Bjørås, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm-Mathisen, J., Seeberg, E., & Kanner, B. I. (1992) · Nature · doi:10.1038/360464a0 · Cited by 1,232
Storck, T., Schulte, S., Hofmann, K., & Stoffel, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10955 · Cited by 1,183 · cited 1×
“Activated microglia and reactive astrocytes release large amounts of glutamate (Takeuchi et al., 2006; Wetherington et al., 2008).”
BackgroundShigemoto, R., Kinoshita, A., Wada, E., Nomura, S., Ohishi, H., Takada, M., Flor, P. J., Neki, A., Abe, T., Nakanishi, S., et al. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07503.1997 · Cited by 1,116
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,109
Kanai, Y., Segawa, H., Miyamoto, K.-I., Uchino, H., Takeda, E., & Endou, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23629 · Cited by 1,109 · cited 1×
“…and histone acetyltransferases (HATs) are distinctly homogeneous, and the HATs are a family of amino acid transporters that are linked by the light chain and the heavy chain through disulfide bonds (François et al., 2004). xCT and 4F2hc are both highly expressed in the brain (Kanai et al., 1998).”
BackgroundMurphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L., & Coyle, J. T. (1989) · Neuron · doi:10.1016/0896-6273(89)90043-3 · Cited by 1,029 · cited 7×
“It is widely distributed and involved in a variety of functions and metabolic processes in the central nervous system (CNS) (Murrough et al., 2017; Madji Hounoum et al., 2018; Wang et al., 2018).”
BackgroundInfluentialInflammation after trauma: Microglial activation and traumatic brain injury
Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., Gentleman, S., Heckemann, R. A., Gunanayagam, K., Gelosa, G., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22455 · Cited by 999
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex
Arriza, J., Fairman, W., Wadiche, J., Murdoch, G., Kavanaugh, M., & Amara, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05559.1994 · Cited by 993
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 966
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1008 · Cited by 939 · cited 1×
“Compared with that of other iGluRs, the activity of NMDARs is inhibited via a so-called Mg2+ block, which is removed via membrane depolarization (Vargas-Caballero and Robinson, 2004).”
BackgroundArriza, J. L., Eliasof, S., Kavanaugh, M. P., & Amara, S. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4155 · Cited by 912
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909 · cited 1×
“However, most NMDAR antagonists are competitive antagonists that can affect the physiological function of the brain and have negative side effects (Lipton, 2006).”
BackgroundStoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity.
Sibson, N. R., Dhankhar, A., Mason, G. F., Rothman, D. L., Behar, K. L., & Shulman, R. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.316 · Cited by 897
Lehre, K., Levy, L., Ottersen, O., Storm-Mathisen, J., & Danbolt, N. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01835.1995 · Cited by 889
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Flux coupling in a neuronal glutamate transporter
Zerangue, N., & Kavanaugh, M. P. (1996) · Nature · doi:10.1038/383634a0 · Cited by 846 · cited 2×
“These transporters cooperate with each glutamate (or asparaginase) molecule in the co-transport of two to three Na ions and a proton and cooperate with the reverse transport of one K ion (Zerangue and Kavanaugh, 1996).”
BackgroundChaudhry, F. A., Lehre, K. P., Lookeren Campagne, M. V., Ottersen, O. P., Danbolt, N. C., & Storm-Mathisen, J. (1995) · Neuron · doi:10.1016/0896-6273(95)90158-2 · Cited by 826 · cited 1×
“Astrocytes expressing high levels of excitatory amino acid transporters (EAATs) sequester excess glutamate at synapses (Chaudhry et al., 1995).”
BackgroundPathogenic Lysosomal Depletion in Parkinson's Disease
Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1920-10.2010 · Cited by 825
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity
Arundine, M., & Tymianski, M. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00141-6 · Cited by 820
The Tetrameric Structure of a Glutamate Receptor Channel
Rosenmund, C., Stern-Bach, Y., & Stevens, C. F. (1998) · Science · doi:10.1126/science.280.5369.1596 · Cited by 794
Structure of a glutamate transporter homologue from Pyrococcus horikoshii
Yernool, D., Boudker, O., Jin, Y., & Gouaux, E. (2004) · Nature · doi:10.1038/nature03018 · Cited by 783
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749 · cited 1×
“When cystine absorption is blocked, intracellular GSH consumption is much faster than protein synthesis (Tan et al., 1998).”
BackgroundSelf-citationGlutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
The Regulation of Reactive Oxygen Species Production during Programmed Cell Death
Tan, S., Sagara, Y., Liu, Y., Maher, P., & Schubert, D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.6.1423 · Cited by 730
Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity
Nakanishi, S. (1994) · Neuron · doi:10.1016/0896-6273(94)90043-4 · Cited by 712 · cited 1×
“In the CNS, glutamate is present in more than one type of cell and distributed in many subcellular compartments, including the cytoplasm and mitochondria (Nedergaard et al., 2002).”
BackgroundCATs and HATs: the SLC7 family of amino acid transporters
Verrey, F., Closs, E. I., Wagner, C. A., Palacin, M., Endou, H., & Kanai, Y. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1086-z · Cited by 710 · cited 1×
“…and histone acetyltransferases (HATs) are distinctly homogeneous, and the HATs are a family of amino acid transporters that are linked by the light chain and the heavy chain through disulfide bonds (François et al., 2004). xCT and 4F2hc are both highly expressed in the brain (Kanai et al., 1998).”
BackgroundNeurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease
Hutchison, W. D., Allan, R. J., Opitz, H., Levy, R., Dostrovsky, J. O., Lang, A. E., & Lozano, A. M. (1998) · Annals of Neurology · doi:10.1002/ana.410440407 · Cited by 702
Schoepp, D. D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 690 · cited 6×
“It should be noted that, in addition to acting as a neurotransmitter, glutamic acid also acts as a metabolic precursor of GABA and various amino acid derivatives (Shen et al., 1999).”
BackgroundInfluentialMetabolism and role of glutamate in mammalian brain
Erecińska, M., & Silver, I. A. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90013-7 · Cited by 682 · cited 1×
“In summary, neuronal glutamate is produced/obtained in two ways: (1) from glucose and amino acid derivatives through energy metabolism; and (2) recovery of glutamate from glutamine via glutamate reuptake (Erecinska and Silver, 1990).”
BackgroundMetabotropic glutamate receptors: From the workbench to the bedside
Nicoletti, F., Bockaert, J., Collingridge, G. L., Conn, P. J., Ferraguti, F., Schoepp, D. D., Wroblewski, J. T., & Pin, J. P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.022 · Cited by 653 · cited 1×
“Subtypes of group II (mGluR2, mGluR3) and group III (mGluR4, mGluR6, mGluR7, and mGluR8) are coupled with Gi/Go to activate MAP kinase and PI-3-kinase pathways and negatively regulate adenylate cyclase (Iacovelli et al., 2010; Niswender and Conn, 2010; Nicoletti et al., 2011).”
BackgroundSheldon, A. L., & Robinson, M. B. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.012 · Cited by 594
Glutamate Transporter Protein Subtypes Are Expressed Differentially during Rat CNS Development
Furuta, A., Rothstein, J. D., & Martin, L. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08363.1997 · Cited by 552
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534 · cited 1×
“The increase of free radicals is particularly important for the pathogenesis of PD, because dopaminergic neurons in the SNpc are particularly susceptible to oxidative stress (Julie and Patrik, 2002; Yuan et al., 2008; Mosharov et al., 2009; Benjamin et al., 2010).”
BackgroundCleavage of the Plasma Membrane Na+/Ca2+ Exchanger in Excitotoxicity
Bano, D., Young, K. W., Guerin, C. J., LeFeuvre, R., Rothwell, N. J., Naldini, L., Rizzuto, R., Carafoli, E., & Nicotera, P. (2005) · Cell · doi:10.1016/j.cell.2004.11.049 · Cited by 533
Oxytosis: a novel form of programmed cell death
Shirlee Tan, B. S. P., David Schubert, B. S. P., & Pamela Maher, B. S. P. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394741 · Cited by 522 · cited 1×
“EAAT2-knockout mice exhibit fatal spontaneous epilepsy and increased sensitivity to acute cortical injury (Tanaka et al., 1997).”
BackgroundImmunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain
Shigemoto, R., Nomura, S., Ohishi, H., Sugihara, H., Nakanishi, S., & Mizuno, N. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90227-c · Cited by 520 · cited 1×
“Group-I mGluRs are mainly located in the post-synaptic density near ionotropic receptors, the function of which is to regulate the excitability of neurons (Shigemoto et al., 1993, 1997).”
BackgroundA Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion
Li, Y., Maher, P., & Schubert, D. (1997) · Neuron · doi:10.1016/s0896-6273(00)80953-8 · Cited by 514
Invited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492 · cited 1×
“The Lewy body is thought to be an aggregating response in cells (Mikiei et al., 2004), which suggests that their function may be related to protein folding and aggregation defects (Mikiei et al., 2004; Kovacs, 2015) and may have protective effects on nerve endings (Sreeganga et al., 2005).”
BackgroundTargeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482 · cited 1×
“Group-I mGluRs activate phospholipase C (PLC) to produce inositol 1,4,5 triphosphate (IP3) and diacylglycerol, each of which has multiple secondmessenger roles (Nakanishi, 1994; Joly et al., 1995; Pin and Duvoisin, 1995).”
BackgroundPajarillo, E., Rizor, A., Lee, J., Aschner, M., & Lee, E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.002 · Cited by 478
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13 C NMR
Shen, J., Petersen, K. F., Behar, K. L., Brown, P., Nixon, T. W., Mason, G. F., Petroff, O. A. C., Shulman, G. I., Shulman, R. G., & Rothman, D. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8235 · Cited by 462 · cited 1×
“It should be noted that, in addition to acting as a neurotransmitter, glutamic acid also acts as a metabolic precursor of GABA and various amino acid derivatives (Shen et al., 1999).”
BackgroundMechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
Saggu, H., Cooksey, J., Dexter, D., Wells, F. R., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454
Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452 · cited 1×
“In addition, the oxidation of lipids, proteins, and DNA, and the increase of total iron content in the SNpc of PD patients support the enhancement of the oxidation stress (Floor and Wetzel, 1998; Dexter et al., 2010).”
BackgroundBeyond the role of glutamate as a neurotransmitter
Nedergaard, M., Takano, T., & Hansen, A. J. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn916 · Cited by 450 · cited 1×
“The circulation of glutamate/glutamine in astrocytes and neurons is called the glutamate–glutamine cycle (Niciu et al., 2012).”
BackgroundAggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective
Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T., & Mouradian, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310994200 · Cited by 422
Norden, D. M., Muccigrosso, M. M., & Godbout, J. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.028 · Cited by 413 · cited 1×
“Increased levels of extracellular glutamate, particularly asynchronistic glutamate levels, cause cellular damage when excitatory neurotransmission is sufficiently aberrant (Pitt et al., 2000; Ouardouz et al., 2009).”
BackgroundZou, J. Y., & Crews, F. T. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.014 · Cited by 410 · cited 1×
“Studies have shown that TNF-α—when used alone in organotypic hippocampal–entorhinal cortex brain slices—causes minor neuronal damage; however, when highfrequency glutamate concentrations are increased, neurotoxicity is greatly accelerated (Zou and Crews, 2005).”
BackgroundAstrocytes in the Epileptic Brain
Wetherington, J., Serrano, G., & Dingledine, R. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.002 · Cited by 389 · cited 2×
“Under pathological conditions, activated microglia and reactive astrocytes release large amounts of glutamate (Hideyuki et al., 2006; Wetherington et al., 2008).”
BackgroundLevine, R. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44305-5 · Cited by 363 · cited 1×
“These two enzymes play crucial roles in glutamate metabolism, and both are sensitive to oxidative stress in the body in an inflammatory environment (Levine, 1983; Aguirre et al., 1989).”
BackgroundGlutamate Metabolism in the Brain Focusing on Astrocytes
Schousboe, A., Scafidi, S., Bak, L. K., Waagepetersen, H. S., & McKenna, M. C. (2014) · Advances in Neurobiology · doi:10.1007/978-3-319-08894-5_2 · Cited by 363 · cited 1×
“In the brain, glutamate can be directly synthesized de novo by astrocytes or indirectly produced from glucose molecules through the actions of pyruvate dehydrogenase and astrocytespecific enzyme pyruvate carboxylase (Krzyżanowska Pomierny et al., 2014; Schousboe et al., 2014).”
BackgroundHassani, O.-K., Mouroux, M., & Féger, J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00535-8 · Cited by 345
Gu, X.-L., Long, C.-X., Sun, L., Xie, C., Lin, X., & Cai, H. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-12 · Cited by 340 · cited 1×
“…model of mutant alpha-synuclein (A53T), experiments showed that alpha-synuclein accumulation in astrocytes affected glutamate transport, triggering a rise of extracellular glutamatergic concentrations and excitotoxicity, which further exacerbated damage to dopaminergic neurons (Gu et al., 2010).”
BackgroundIntraoperative microrecordings of the subthalamic nucleus in Parkinson's disease
Benazzouz, A., Breit, S., Koudsie, A., Pollak, P., Krack, P., & Benabid, A.-L. (2002) · Movement Disorders · doi:10.1002/mds.10156 · Cited by 338 · cited 1×
“proposed that excessive activation of glutamate receptors in nigrostriatal neurons might lead to cellular death via glutamate excitotoxicity (Bergman et al., 1994; Hassani et al., 1996; Benazzouz et al., 2002; Hutchison et al., 2010).”
BackgroundOverview of glutamatergic neurotransmission in the nervous system
Niciu, M. J., Kelmendi, B., & Sanacora, G. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.08.008 · Cited by 329
Brown, G. C., & Vilalta, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.031 · Cited by 311 · cited 1×
“can change the effects of inflammatory factors, such as TNFα and IL-1β, and can also enhance glutamine enzymes and inhibit glutamine dehydrogenase and glutamine synthase, thus enhancing glutamate excitotoxicity (Brown and Vilalta, 2015).”
BackgroundJoly, C., Gomeza, J., Brabet, I., Curry, K., Bockaert, J., & Pin, J. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03970.1995 · Cited by 278 · cited 1×
“Group-I mGluRs activate phospholipase C (PLC) to produce inositol 1,4,5 triphosphate (IP3) and diacylglycerol, each of which has multiple secondmessenger roles (Nakanishi, 1994; Joly et al., 1995; Pin and Duvoisin, 1995).”
BackgroundPinheiro, P., & Mulle, C. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0265-6 · Cited by 269 · cited 13×
“Additionally, for non-Ca2+-permeable AMPA receptors, studies have shown that low-dose TNF-α plays a neuroprotective role through tissue necrosis factor receptor-2 (TNFR-2), while high-dose TNF-α increases the synaptic transport of calcium-permeable AMPARs through the TNFR-1 and enhances excitotoxicity in a concentrati…”
BackgroundInfluentialNeuroenergetics: Calling Upon Astrocytes to Satisfy Hungry Neurons
Pellerin, L., & Magistretti, P. J. (2004) · The Neuroscientist · doi:10.1177/1073858403260159 · Cited by 267 · cited 1×
“…acid cycle, and then the transfer of ammonia yields alpha-ketoglutarate, which receives an ammonia donor from a chain of amino acids—such as leucine, isoleucine, and valine—and a variety of amino donors, such as aspartic acid, gamma-aminobutyric acid (GABA), and alanine (Luc and Magistretti, 2004).”
BackgroundChen, W., Mahadomrongkul, V., Berger, U. V., Bassan, M., DeSilva, T., Tanaka, K., Irwin, N., Aoki, C., & Rosenberg, P. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1586-03.2004 · Cited by 266 · cited 1×
“GLT-1 is not only expressed in astrocytes; its splice variant GLT-1a is also expressed in the axons of hippocampal neurons, which may contribute significantly to glutamate uptake into the axonal terminal (Schmitt et al., 1996; Chen et al., 2004; Berger et al., 2005).”
BackgroundOxidative Glutamate Toxicity Can Be a Component of the Excitotoxicity Cascade
Schubert, D., & Piasecki, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07455.2001 · Cited by 253 · cited 2×
“The second part involves 20–30% of the cell death pathway and has characteristics of oxidative glutamate toxicity, because it can be inhibited specifically by vitamin E, group I metabotropic receptor agonists, a caspase inhibitor, elevated extracellular cystine, and the removal of extracellular glutamate (Schubert and…”
BackgroundBiogenic amine transporters: regulation in flux
Blakely, R. D., & Bauman, A. L. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00088-x · Cited by 249 · cited 1×
“, 1997a); in many neurons, however, they appear to be located in postsynaptic elements, indicating that they do not participate in the delivery cycle as monoamine transporters do (Blakely and Bauman, 2000; Torres and Caron, 2003).”
BackgroundCrystal Structure of a Procaspase-7 Zymogen
Chai, J., Wu, Q., Shiozaki, E., Srinivasula, S. M., Alnemri, E. S., & Shi, Y. (2001) · Cell · doi:10.1016/s0092-8674(01)00544-x · Cited by 246 · cited 1×
“Synaptic and extrasynaptic NMDAR activation exert opposing neural protective and neurotoxic effects, respectively, and these processes involve a variety of corresponding neuroprotective and apoptotic pathways (Chai et al., 2001).”
BackgroundThe role of glutamate in central nervous system health and disease – A review
Platt, S. R. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2005.11.007 · Cited by 245 · cited 2×
“These subtypes are located presynaptically and act as selfreceptors to inhibit the release of glutamate and/or GABA (Schoepp, 2001). mGluRs have seven transmembrane domains (Platt, 2007), as do other metabotropic receptors, but they are not ion channels.”
BackgroundCalcium, Excitotoxins, and Neuronal Death in the Braina
SIESJÖ, B. K., BENGTSSON, F., GRAMPP, W., & THEANDER, S. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb12513.x · Cited by 237 · cited 1×
“The excitotoxic cascade is triggered by excess extracellular glutamate, which may eventually lead to cell injury and death (Siesjö et al., 1989).”
BackgroundFuruta, A., Martin, L. J., Lin, C.-L. G., Dykes-Hoberg, M., & Rothstein, J. D. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00252-2 · Cited by 235
Conti, F. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.2.108 · Cited by 227 · cited 1×
“, 1994), oligodendrocytes (Conti et al., 1998), and other glutamate neurons.”
BackgroundIacovelli, L., Bruno, V., Salvatore, L., Melchiorri, D., Gradini, R., Caricasole, A., Barletta, E., De Blasi, A., & Nicoletti, F. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00929.x · Cited by 191
Yan, Y., Liu, J., Wei, C., Li, K., Xie, W., Wang, Y., & Cheng, H. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm047 · Cited by 159 · cited 1×
“The increase of free radicals is particularly important for the pathogenesis of PD, because dopaminergic neurons in the SNpc are particularly susceptible to oxidative stress (Julie and Patrik, 2002; Yuan et al., 2008; Mosharov et al., 2009; Benjamin et al., 2010).”
BackgroundSchmitt, A., Asan, E., Püschel, B., Jöns, T., & Kugler, P. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00477-7 · Cited by 157 · cited 1×
“GLT-1 is not only expressed in astrocytes; its splice variant GLT-1a is also expressed in the axons of hippocampal neurons, which may contribute significantly to glutamate uptake into the axonal terminal (Schmitt et al., 1996; Chen et al., 2004; Berger et al., 2005).”
BackgroundAbusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity
Manev, H., Costa, E., Wroblewski, J. T., & Guidotti, A. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2165013 · Cited by 149
Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases
Lin, C.-L. G., Kong, Q., Cuny, G. D., & Glicksman, M. A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.122 · Cited by 146
Bid-induced release of AIF from mitochondria causes immediate neuronal cell death
Landshamer, S., Hoehn, M., Barth, N. D., Duvezin‐Caubet, S., Schwake, G., Tobaben, S., Kazhdan, I., Becattini, B., Stefan Zahler, A., Vollmar, A. M., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.78 · Cited by 143
Crisman, T. J., Qu, S., Kanner, B. I., & Forrest, L. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908570106 · Cited by 142 · cited 2×
“…work has shown that EAATs contribute to the removal of synaptic glutamate, and the protein structures and functions of these transporters are closely related (Shaogang and Kanner, 2008; Crisman et al., 2009; Teichman et al., 2009; Zhang and Qu, 2012; Yunlong et al., 2014; Rong et al., 2015).”
BackgroundSelf-citationRequirement for cGMP in Nerve Cell Death Caused by Glutathione Depletion
Li, Y., Maher, P., & Schubert, D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1317 · Cited by 140
Butcher, S. P., Sandberg, M., Hagberg, H., & Hamberger, A. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05576.x · Cited by 130 · cited 1×
“In mammals, there is 5–10 mmol glutamate per kilogram of CNS tissue (Butcher et al., 2010), which is higher than levels of virtually all other neurotransmitters.”
BackgroundContrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC.
Makowske, M., & Christensen, H. N. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83829-2 · Cited by 130
Meredith, G. E., Totterdell, S., Beales, M., & Meshul, C. K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.06.005 · Cited by 128
Gardoni, F., Boraso, M., Zianni, E., Corsini, E., Galli, C. L., Cattabeni, F., Marinovich, M., Di Luca, M., & Viviani, B. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-14 · Cited by 124 · cited 1×
“In addition, it has been demonstrated that the interaction between IL-1β receptors and NMDARs can also lead to increased excitotoxicity, and the expression of IL-1β receptors on the postsynaptic membrane is stimulated by NMDAR activation (Gardoni et al., 2011).”
BackgroundExpression of glutamate transporters in rat optic nerve oligodendrocytes
Domercq, M., Sánchez‐Gómez, M. V., Areso, P., & Matute, C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00639.x · Cited by 124
Small-Scale Molecular Motions Accomplish Glutamate Uptake in Human Glutamate Transporters
Koch, H. P., & Larsson, H. P. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4138-04.2005 · Cited by 119
Ubiquitination of α-synuclein and autophagy in Parkinson's disease
Engelender, S. (2008) · Autophagy · doi:10.4161/auto.5604 · Cited by 114
Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism
Sonsalla, P. K., Albers, D. S., & Zeevalk, G. D. (1998) · Amino Acids · doi:10.1007/bf01345245 · Cited by 114 · cited 1×
“The Lewy body is thought to be an aggregating response in cells (Mikiei et al., 2004), which suggests that their function may be related to protein folding and aggregation defects (Mikiei et al., 2004; Kovacs, 2015) and may have protective effects on nerve endings (Sreeganga et al., 2005).”
BackgroundLöschmann, P. A., de Groote, C., Smith, L. A., Wüllner, U., Fischer, G., Kemp, J. A., Jenner, P. G., & Klockgether, T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.018 · Cited by 109
12/15‐Lipoxygenase targets neuronal mitochondria under oxidative stress
Pallast, S., Arai, K., Wang, X., Lo, E. H., & Van Leyen, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06379.x · Cited by 109 · cited 4×
“The specific EAAT glutamate aspartate transporter (GLAST) (Storck et al., 1992) is also known as excitatory amino acid transporter 1 (EAAT1) (Arriza et al., 1994), and the EAAT glutamate transporter 1 (GLT-1) (Pines et al., 1992) is also known as excitatory amino acid transporter 2 (EAAT2) (Arriza…”
BackgroundInfluentialChung, E. K. Y., Chen, L. W., Chan, Y. S., & Yung, K. K. L. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21852 · Cited by 105 · cited 1×
“The expression of EAAT2 in PD animal models has been studied, and the downregulation of EAAT2 has been found in both 6-hydroxydopamine and acute 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine models in the mouse striatum (Holmer et al., 2005; Chung et al., 2010).”
BackgroundBerger, U. V., DeSilva, T. M., Chen, W., & Rosenberg, P. A. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20737 · Cited by 104 · cited 1×
“GLT-1 is not only expressed in astrocytes; its splice variant GLT-1a is also expressed in the axons of hippocampal neurons, which may contribute significantly to glutamate uptake into the axonal terminal (Schmitt et al., 1996; Chen et al., 2004; Berger et al., 2005).”
BackgroundGlutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors
Ouardouz, M., Coderre, E., Zamponi, G. W., Hameed, S., Yin, X., Trapp, B. D., & Stys, P. K. (2009) · Annals of Neurology · doi:10.1002/ana.21539 · Cited by 104 · cited 1×
“In addition, an antagonist of NMDAR attenuated motor symptoms in an MPTP-induced PD animal model (Pajarillo et al., 2019).”
BackgroundVargas-Caballero, M., & Robinson, H. P. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1380-04.2004 · Cited by 100
Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson’s disease model
Zhang, Y., He, X., Meng, X., Wu, X., Tong, H., Zhang, X., & Qu, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.454 · Cited by 99
Self-citationAbdul-Ghani, M. A., Valiante, T. A., Carlen, P. L., & Pennefather, P. S. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.4.2691 · Cited by 99
Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein
Watson, J. B., Hatami, A., David, H., Masliah, E., Roberts, K., Evans, C. E., & Levine, M. S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.021 · Cited by 99 · cited 1×
“reported that the relative release of glutamate was inhibited by the knockout of alphasynuclein in a mouse model in SN terminals (Watson et al., 2009).”
BackgroundDynamics and modulation of metabotropic glutamate receptors
Rondard, P., & Pin, J. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.001 · Cited by 95
Yernool, D., Boudker, O., Folta-Stogniew, E., & Gouaux, E. (2003) · Biochemistry · doi:10.1021/bi030161q · Cited by 95
Glutamate transporters in brain ischemia: to modulate or not?
Krzyżanowska, W., Pomierny, B., Filip, M., & Pera, J. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.1 · Cited by 92
Bonsi, P., Cuomo, D., Persis, C. D., Centonze, D., Bernardi, G., Calabresi, P., & Pisani, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.05.012 · Cited by 87 · cited 1×
“, 1993) or induction of postsynaptic responses (Chu and Hablitz, 2000; Endoh, 2004; Bonsi et al., 2005; Platt, 2007).”
BackgroundHoeijmakers, L., Heinen, Y., van Dam, A.-M., Lucassen, P. J., & Korosi, A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00398 · Cited by 85
Up‐regulation of hippocampal glutamate transport during chronic treatment with sodium valproate
Hassel, B., Iversen, E. G., Gjerstad, L., & Taubøll, E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00349.x · Cited by 82
Epigenetic regulation of neuron‐dependent induction of astroglial synaptic protein GLT1
Yang, Y., Gozen, O., Vidensky, S., Robinson, M. B., & Rothstein, J. D. (2010) · Glia · doi:10.1002/glia.20922 · Cited by 82 · cited 2×
“Research has indicated that the GLT-1 promoter has multiple methylated CpG islands (Zschocke et al., 2007; Yang et al., 2010), and transcription activation requires demethylation of the GLT-1 promoter.”
BackgroundNeuronal glutamate transporter EAAT4 is expressed in astrocytes
Hu, W., Walters, W. M., Xia, X., Karmally, S., & Bethea, J. R. (2003) · Glia · doi:10.1002/glia.10268 · Cited by 78
Zhang, Y., Tan, F., Xu, P., & Qu, S. (2016) · Neural Plasticity · doi:10.1155/2016/8941327 · Cited by 73
Self-citationGras, G., Chrétien, F., Vallat‐Decouvelaere, A., Le Pavec, G., Porcheray, F., Bossuet, C., Léone, C., Mialocq, P., Dereuddre‐Bosquet, N., Clayette, P., et al. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00020.x · Cited by 67
DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells
Zschocke, J., Allritz, C., Engele, J., & Rein, T. (2007) · Glia · doi:10.1002/glia.20497 · Cited by 67 · cited 2×
“Research has indicated that the GLT-1 promoter has multiple methylated CpG islands (Zschocke et al., 2007; Yang et al., 2010), and transcription activation requires demethylation of the GLT-1 promoter.”
BackgroundHüls, S., Högen, T., Vassallo, N., Danzer, K. M., Hengerer, B., Giese, A., & Herms, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07254.x · Cited by 66
Blaylock, R. (2017) · Surgical Neurology International · doi:10.4103/sni.sni_441_16 · Cited by 66 · cited 3×
“…have shown that low-dose TNF-α plays a neuroprotective role through tissue necrosis factor receptor-2 (TNFR-2), while high-dose TNF-α increases the synaptic transport of calcium-permeable AMPARs through the TNFR-1 and enhances excitotoxicity in a concentration-dependent manner (Blaylock, 2017).”
BackgroundEndoh, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.074 · Cited by 65 · cited 1×
“This may lead to changes in synaptic excitability, such as presynaptic inhibition of neurotransmission (Sladeczek et al., 1993) or induction of postsynaptic responses (Chu and Hablitz, 2000; Endoh, 2004; Bonsi et al., 2005; Platt, 2007).”
BackgroundSladeczek, F., Momiyama, A., & Takahashi, T. (1993) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1993.0117 · Cited by 65 · cited 1×
“Previous studies have shown that glutamate excitotoxicity may induce the degeneration of dopaminergic neurons and concomitant motor dysfunction in PD (Sonsalla et al., 1998; Meredith et al., 2009).”
BackgroundManev, H., Favaron, M., Siman, R. G., Guidotti, A., & Costa, E. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08292.x · Cited by 60
The biomarkers of immune dysregulation and inflammation response in Parkinson disease
Chen, L., Mo, M., Li, G., Cen, L., Wei, L., Xiao, Y., Chen, X., Li, S., Yang, X., Qu, S., et al. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0063-3 · Cited by 53 · cited 1×
“It has been reported that macrophages may undergo pathological diffusion from blood vessels to the CNS during inflammation and transform into microglia cells, which promote the pathological development of intracranial nervous system diseases (Chen et al., 2016).”
BackgroundSelf-citationThe Structural and Functional Units of Heteromeric Amino Acid Transporters
Fernández, E., Jiménez-Vidal, M., Calvo, M., Antonio Zorzano, A., Tebar, F., Palacín, M., & Chillarón, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604049200 · Cited by 51 · cited 1×
“However, it has been shown that the substitution of rBAT for 4F2hc heavy chain does not affect the function of the transporter (Wang et al., 2003; Fernández et al., 2006).”
BackgroundHolmer, H. K., Keyghobadi, M., Moore, C., & Meshul, C. K. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.08.003 · Cited by 49
Johnson, J., Pajarillo, E. A. B., Karki, P., Kim, J., Son, D., Aschner, M., & Lee, E.-S. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.05.001 · Cited by 49
Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson’s Disease
Wu, X., Meng, X., Tan, F., Jiao, Z., Zhang, X., Tong, H., He, X., Luo, X., Xu, P., & Qu, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00683 · Cited by 41
Self-citationYang, J., Hertz, E., Zhang, X., Leinartaité, L., Lundius, E. G., Li, J., & Svenningsson, P. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.023 · Cited by 37 · cited 1×
“Additionally, overexpression of alpha-synuclein increases the phosphorylation of NMDARs, thereby increasing the expression of NR1 and NR2B subunits and increasing the sensitivity of NMDARs to glutamate excitotoxicity (Yang et al., 2016).”
BackgroundErratum: Cloning and expression of a rat brain L-glutamate transporter
Pines, G., Danbolt, N. C., Bjørås, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm‐Mathisen, J., Seeberg, E. C., & Kanner, B. I. (1992) · Nature · doi:10.1038/360768a0 · Cited by 36
The CpG island shore of the GLT‐1 gene acts as a methylation‐sensitive enhancer
Perišić, T., Holsboer, F., Rein, T., & Zschocke, J. (2012) · Glia · doi:10.1002/glia.22353 · Cited by 34
Expression of the activity of cystine/glutamate exchange transporter, system xc−, by xCT and rBAT
Wang, H., Tamba, M., Kimata, M., Sakamoto, K., Bannai, S., & Sato, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00808-8 · Cited by 31 · cited 1×
“However, it has been shown that the substitution of rBAT for 4F2hc heavy chain does not affect the function of the transporter (Wang et al., 2003; Fernández et al., 2006).”
BackgroundStimulation of synaptoneurosome glutamate release by monomeric and fibrillated α‐synuclein
Sarafian, T. A., Littlejohn, K., Yuan, S. Y., Fernandez, C., Cilluffo, M. C., Koo, B., Whitelegge, J. P., & Watson, J. B. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24024 · Cited by 29
Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells
Wang, X., Wang, J., Lin, S., Geng, Y., Wang, J., & Jiang, B. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-44 · Cited by 25 · cited 1×
“In this case, oxidative stress in the SNpc leads to excessive peroxide formation, and glutathione deficiency leads to a decreased ability of the brain to remove H2O2, and continuous accumulation of H2O2 induces cellular death (Wang et al., 2008; Saggu et al., 2010).”
BackgroundSelf-citationBianchi, M. G., Franchi‐Gazzola, R., Reia, L., Allegri, M., Uggeri, J., Chiu, M., Sala, R., & Bussolati, O. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.055 · Cited by 21 · cited 1×
“Studies have reported that valproic acid (VPA), which is a histone deacetylase (HDAC) inhibitor can increase the levels of GLAST, GLT-1, and EAAC1 mRNA/protein in astrocytes and oligodendrocytes, thereby combating neurotoxicity (Hassel et al., 2001; Bianchi et al., 2012; Johnson et al., 2018).”
BackgroundThe Metabolic Disturbances of Motoneurons Exposed to Glutamate
Hounoum, B. M., Blasco, H., Coque, E., Vourc’h, P., Emond, P., Corcia, P., Andres, C. R., Raoul, C., & Mavel, S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0945-8 · Cited by 19
Xu, F., Wang, T., Cai, Q., Yang, W., Fan, H.-H., & Yi, J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.235059 · Cited by 15 · cited 7×
“It is widely distributed and involved in a variety of functions and metabolic processes in the central nervous system (CNS) (Murrough et al., 2017; Madji Hounoum et al., 2018; Wang et al., 2018).”
BackgroundInfluentialZhang, Y., Zhang, X., & Qu, S. (2014) · Amino Acids · doi:10.1007/s00726-014-1731-1 · Cited by 6 · cited 1×
“…work has shown that EAATs contribute to the removal of synaptic glutamate, and the protein structures and functions of these transporters are closely related (Shaogang and Kanner, 2008; Crisman et al., 2009; Teichman et al., 2009; Zhang and Qu, 2012; Yunlong et al., 2014; Rong et al., 2015).”
BackgroundSelf-citation
Cited by
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Wallen, Z. D., Demirkan, A., Twa, G., Cohen, G., Dean, M. N., Standaert, D. G., Sampson, T. R., & Payami, H. (2022) · Nature Communications · doi:10.1038/s41467-022-34667-x · Cited by 346
Kalecký, K., & Bottiglieri, T. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00531-y · Cited by 32
Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light
Geoffroy, C., Berraud-Pache, R., Chéron, N., McCort-Tranchepain, I., Doria, J., Paoletti, P., & Mony, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00247 · Cited by 9
Metadata
- Authors
- Wang, J., Wang, F., Mai, D., & Qu, S.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-11-26
- Volume
- 14
- Pages
- 585584-585584
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W3109598442
- Cited by
- 227
- References
- 144
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.